Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

GABRA6 (Q16445) - Domains And Structures - Molecular Target Synopsis

Click Here to View Molecular Target 3D Synopsis

Select a homology cutoff:
Structural Sequence Similarity Matches
Domains Covered Gene Name (Uniprot) Solved in Complex with Organism PDB Chain Identity E-Value Resolution Ligands Release Date
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RI5_E 37.54 2.0E-53 NAG IVM RI5
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) 6DW1_A 74.83 7.0E-130 NAG ABU BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSC_C 37.16 6.0E-40 A8W
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) 6D6T_A 39.8 7.0E-65 Y01 NAG ABU BMA
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_Q 37.54 2.0E-53 NAG POV
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_Q 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAF_A 43.63 6.0E-71 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUO_B 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDI_B 42.99 1.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUP_E 35.54 8.0E-71 NAG ABU BMA MAN DZP
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_R 37.54 2.0E-53 POV
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (57%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) 6DW1_B 41.69 1.0E-66 NAG BMA
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5OJM_D 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_D 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) 6D6U_C 39.8 7.0E-65 Y01 NAG ABU BMA
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867) 6I53_B 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUK_B 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIO_B 42.99 2.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUG_A 61.72 0 NAG BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_D 37.54 2.0E-53 NAG LMT POV
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5O8F_E 50.65 2.0E-81 NAG BMA MAN P9N
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867) 6I53_E 35.54 8.0E-71 NAG POV BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6I_A 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIN_A 42.99 1.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) - 4COF_E 41.12 2.0E-66 NAG BMA BEN
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_D 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - 5OSA_D 37.16 6.0E-40 Y01 D12
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIF_D 37.54 2.0E-53 IVM GLU
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_A 37.54 2.0E-53 NAG POV
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_I 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RHW_E 37.54 2.0E-53 NAG
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_F 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) 6D6U_A 39.8 7.0E-65 Y01 NAG ABU BMA
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUK_D 61.72 0 NAG BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_G 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) 6A96_B 41.12 3.0E-66 NAG ABU BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUJ_D 61.72 0 NAG ABU BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDH_A 42.99 2.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6I_D 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIO_E 42.99 2.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - 5OSA_C 37.16 6.0E-40 Y01 D12
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) Gabrg2 (P18508) Gabrb1 (P15431), Gabra1 (P62813) 6DW1_D 48.3 1.0E-109 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) 6D6U_D 74.1 3.0E-130 Y01 FYP NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIA_B 37.54 2.0E-53 LMT UND
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_B 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAE_D 43.63 6.0E-71 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5O8F_D 50.65 2.0E-81 NAG BMA MAN P9N
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_B 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_C 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAD_D 43.63 6.0E-71 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSB_E 37.16 6.0E-40 A8Z
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUK_E 35.54 8.0E-71 NAG H0Z BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSC_B 37.16 6.0E-40 Y01 A8W
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIO_D 42.99 2.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (57%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) 6DW0_E 41.69 1.0E-66 NAG BMA
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAD_B 43.63 6.0E-71 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_C 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) 6HUO_C 47.38 5.0E-109 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIN_D 42.99 1.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5CFB_A 42.99 2.0E-72 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAF_E 43.63 6.0E-71 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5CFB_C 42.99 2.0E-72 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867) GABRG2 (P18507), GABRB3 (P28472) 6I53_A 61.72 0 NAG POV BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) - 4COF_A 41.12 2.0E-66 NAG BMA BEN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDH_E 42.99 2.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) 6A96_E 41.12 3.0E-66 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUP_D 61.72 0 NAG BMA PIO MAN DZP
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSB_A 37.16 6.0E-40 A8Z
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5OJM_B 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_I 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel transmembrane region (43%) (view alignment) GLRA1 (P23415) - 1VRY_A 61.67 2.0E-14 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_T 37.54 2.0E-53 NAG LMT POV
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIF_E 37.54 2.0E-53 NAG IVM GLU
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_G 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) 6D6T_C 39.8 7.0E-65 NAG ABU BMA
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_A 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUJ_B 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_P 37.54 2.0E-53 LMT NAG POV
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIA_E 37.54 2.0E-53 IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) - 4COF_C 41.12 2.0E-66 NAG BMA BEN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_S 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSB_C 37.16 6.0E-40 A8Z
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUO_A 61.72 0 NAG ABU BMA PIO MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) 6DW0_C 74.83 7.0E-130 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIF_B 37.54 2.0E-53 LMT NAG IVM UND GLU
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_H 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5O8F_A 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_D 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P08219) 6HUG_B 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDI_D 42.99 1.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAF_C 43.63 6.0E-71 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RI5_B 37.54 2.0E-53 LMT NAG IVM UND
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSB_D 37.16 6.0E-40 -
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - 5OSA_B 37.16 6.0E-40 Y01 D12
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) 6HUJ_C 47.38 5.0E-109 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUP_A 61.72 0 NAG BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUG_D 61.72 0 NAG BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) 6HUK_C 47.38 5.0E-109 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) 6D6U_B 74.1 3.0E-130 Y01 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIO_C 42.99 2.0E-72 NAG 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_P 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIN_B 42.99 1.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_A 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSC_D 37.16 6.0E-40 Y01 A8W
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_J 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDI_A 42.99 1.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_S 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6I_B 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDI_E 42.99 1.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIO_A 42.99 2.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAE_A 43.63 6.0E-71 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAE_B 43.63 6.0E-71 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIF_C 37.54 2.0E-53 NAG GLU
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RI5_D 37.54 2.0E-53 IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRB3 (P28472) 6I53_C 47.38 5.0E-109 NAG
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6I_C 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDH_B 42.99 2.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAE_E 43.63 6.0E-71 NAG
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6B_A 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) 6A96_D 41.12 3.0E-66 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_F 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) 6A96_C 41.12 3.0E-66 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5CFB_E 42.99 2.0E-72 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867) GABRG2 (P18507), GABRB3 (P28472) 6I53_D 61.72 0 NAG POV BMA MAN PIO
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_A 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (57%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) 6DW1_E 41.69 1.0E-66 NAG BMA
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - 5OSA_E 37.16 6.0E-40 Y01 D12
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (69%) (view alignment) GABRG2 (P18507) GABRB2 (P47870), GABRA1 (P14867) 6D6U_E 55.77 6.0E-104 Y01
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P08219) 6HUG_E 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644) GABRB3 (P28472) 6A96_A 68.02 0 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RHW_D 37.54 2.0E-53 IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUP_B 35.54 8.0E-71 NAG ABU BMA MAN DZP
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) 6D6T_B 74.1 3.0E-130 Y01 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSC_E 37.16 6.0E-40 Y01 A8W
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIA_C 37.54 2.0E-53 IVM
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_E 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUO_D 61.72 0 08H NAG BMA PIO MAN
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_E 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_E 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (57%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) 6DW0_B 41.69 1.0E-66 NAG ABU BMA
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_J 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RHW_A 37.54 2.0E-53 LMT IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIN_E 42.99 1.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_T 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAD_C 43.63 6.0E-71 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5OJM_C 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5OJM_E 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) 6DW1_C 74.83 7.0E-130 NAG ABU BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSC_A 37.16 6.0E-40 Y01 A8W
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5CFB_B 42.99 2.0E-72 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RI5_C 37.54 2.0E-53 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) Gabrg2 (P18508) Gabrb1 (P15431), Gabra1 (P62813) 6DW0_D 48.3 1.0E-109 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAD_E 43.63 6.0E-71 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (59%) (view alignment) GLRA1 (P23415) - 2M6I_E 58.06 5.0E-27 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDH_C 42.99 2.0E-72 NAG IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) 6HUP_C 47.38 5.0E-109 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) - 4COF_D 41.12 2.0E-66 NAG BMA BEN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RHW_B 37.54 2.0E-53 LMT NAG IVM UND
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_C 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNW_E 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDH_D 42.99 2.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) 6DW0_A 74.83 7.0E-130 NAG ABU BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RHW_C 37.54 2.0E-53 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAD_A 43.63 6.0E-71 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RI5_A 37.54 2.0E-53 LMT IVM
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) Gabra2 (P26048), glvI (Q7NDN8) - 5OSA_A 37.16 6.0E-40 Y01 D12
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUO_E 35.54 8.0E-71 NAG ABU BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAF_B 43.63 6.0E-71 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUK_A 61.72 0 NAG H0Z BMA PIO MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5VDI_C 42.99 1.0E-72 IVM 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5O8F_B 50.65 2.0E-81 NAG BMA MAN P9N
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAF_D 43.63 6.0E-71 NAG IVM
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (35%) (view alignment) GABRG2 (P18507) GABRB2 (P47870), GABRA1 (P14867) 6D6T_E 56.44 2.0E-87 NAG
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6CDU_B 39.17 3.0E-44 EY4
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIA_D 37.54 2.0E-53 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_R 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glra1 (O93430) - 3JAE_C 43.63 6.0E-71 NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5CFB_D 42.99 2.0E-72 NAG SY9
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) glc-1 (G5EBR3) - 4TNV_C 37.54 2.0E-53 LMT NAG
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) 6HUJ_A 61.72 0 NAG ABU BMA MAN PIO RI5
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (64%) (view alignment) GABRB3 (P28472) - 4COF_B 41.12 2.0E-66 NAG BMA BEN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (79%) (view alignment) GLRA3 (O75311) - 5TIN_C 42.99 1.0E-72 7C6
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRG2 (P18507) GABRA1 (P08219), GABRB3 (P28472) 6HUG_C 47.38 5.0E-109 NAG RI5
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIF_A 37.54 2.0E-53 LMT IVM GLU
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (63%) (view alignment) - 3RIA_A 37.54 2.0E-53 LMT IVM
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_B 39.17 3.0E-44 -
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5OJM_A 50.65 2.0E-81 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) 6D6T_D 74.1 3.0E-130 Y01 FYP NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - 5O8F_C 50.65 2.0E-81 NAG BMA MAN P9N
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (100%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) 6HUJ_E 35.54 8.0E-71 NAG BMA MAN
Neurotransmitter-gated ion-channel ligand binding domain (92%), Neurotransmitter-gated ion-channel transmembrane region (65%) (view alignment) glvI (Q7NDN8), Gabra1 (P62812) - 5OSB_B 37.16 6.0E-40 A8Z
Neurotransmitter-gated ion-channel ligand binding domain (89%), Neurotransmitter-gated ion-channel transmembrane region (70%) (view alignment) GABRA1 (P14867), (E0SJQ4) - 6D1S_H 39.17 3.0E-44 -